ClinicalTrials.gg
CompletedNCT00819286RESTOREUpdated Feb 13, 2018Results posted

Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain

An interventional study of SternaLock Rigid Fixation Plates and wire (control) in Sternal Wound Infection, Sternal Non-union and Pain, sponsored by Zimmer Biomet. Completed at 6 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-02-13.

Sponsored by Zimmer Biomet · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to evaluate sternal osteosynthesis, chest wall pain and return to normal activity in open heart surgery patients who had their breast bone closed either with wires or plates.

Read the detailed description

Median sternotomy patients will be randomized to either wire or rigid fixation groups. A scheduled evaluation period will record clinical parameters. Enrollment has ended with one hundred forty (140) patients.

02

Conditions studied

  • Sternal Wound Infection
  • Sternal Non-union
  • Pain
  • Mediastinitis

Keywords

  • open heart surgery
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's enrollment of 140 is above the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Zimmer Biomet is the lead sponsor of 275 studies on the registry; 28 are open to participants now.

Of its 22 completed or terminated interventional studies of FDA-regulated products, 19 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing median sternotomy;
  • Patients eighteen (18) years of age or older;
  • Patients presenting two or more risk factors such as diabetes mellitus, , obesity ( > 30), osteoporosis, Renal failure, Chronic use, , Redo sternotomy, Neurologic dysfunction severely affecting ambulation,
  • Off mid-line sternotomy
  • bilateral IMA use
  • Long cardio-pulmonary bypass runs
  • Transverse fractures of the sternum

Exclusion criteria

Exclusion Criteria:

  • Patients with a non-standard sternotomy;
  • Patients with an off-midline sternotomy that reduced the bony margin to \<2mm
  • Patients under eighteen (18) years of age;
  • Patients that are pregnant or currently lactating;
  • Patients presenting intra-operative conditions that would require the use of rigid fixation and/or additional post-sternotomy mechanical support beyond wire cerclage due to surgical evaluation,
  • Patients defined within the (NYHA) or Canadian Cardiovascular Society (CCS) functional Class IV for congestive heart failure,
  • Patients presenting emergent/salvage cardiac acuity as defined per the Society of Thoracic Surgeons (STS) guidelines: i.e., patients undergoing cardiopulmonary resuscitation en route to the operating room or prior to induction of anesthesia;
  • Patients undergoing post-operative revision procedures that treat the original sternotomy in such a way as to affect outcome (antibiotic irrigation, debridement or other treatment to the osteotomy);
  • Patients unwilling or unable to return for follow-up;
  • Lacking the ability to follow instructions;
  • Intraoperative death.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
140 participants (actual)

Study arms

  • Active comparator
    wire (control)

    patients will have their sternum closed using wire (stainless steel surgical wire).

    Device: wire (control)

  • Experimental
    SternaLock Rigid Fixation Plates

    patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates.

    Device: SternaLock Rigid Fixation Plates

Interventions

  • DeviceSternaLock Rigid Fixation Plates

    patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates

  • Devicewire (control)

    patients will have their sternum closed using wire (stainless steel surgical wire).

06

What researchers measure

Primary outcomes

  1. CT Scan Evaluation of Sternal Bone Healing

    Quantitative evaluation of sternal bone healing at 5 anatomical locations along the sternum using a 6 point quantitative scale (0= no healing and 5= complete healing)

    Time frame: 3 and 6 Months

  2. Activity Based Total Visual Analog Pain Score

    Postoperative VAS pain scores (scale of 0-10 for each; 0= no pain, 10= worst pain imaginable) were evaluated as a function of resting, coughing, sneezing and general movement. The sum of these was used to derive an "Activity Based Total Visual Analog Pain Score", (scale of 0-40; 0= no pain, 40= worst pain imaginable). For this primary endpoint analysis, the total score at 6 months was evaluated.

    Time frame: 6 months

07

Results

Posted Mar 15, 2012

Participant flow

Prospective, randomized trial at 5 US sites and 1 European site. Patient enrollment occurred between November 2008 and May 2010.

Participant flow — Overall Study
MilestoneWire (Control)Plates
Started7070
Completed5645
Not completed1425

Outcome measures

PrimaryCT Scan Evaluation of Sternal Bone Healing

Quantitative evaluation of sternal bone healing at 5 anatomical locations along the sternum using a 6 point quantitative scale (0= no healing and 5= complete healing)

Time frame:
3 and 6 Months
Reported as:
Mean · units on a scale
CT Scan Evaluation of Sternal Bone Healing
units on a scaleWire (Control)Plates
3 Month CT Scan (n=25 wire, n=27 plates)0.9 ± 0.81.7 ± 1.1
6 Month CT Scan (n=26 wire, n=23 plates)2.2 ± 1.13.2 ± 1.6
Statistical analysis
  • Wire (Control) vs Plates · t-test, 2 sided · p = 0.003 · Mean difference (final values): 0
  • Wire (Control) vs Plates · t-test, 2 sided · p = 0.01
PrimaryActivity Based Total Visual Analog Pain Score

Postoperative VAS pain scores (scale of 0-10 for each; 0= no pain, 10= worst pain imaginable) were evaluated as a function of resting, coughing, sneezing and general movement. The sum of these was used to derive an "Activity Based Total Visual Analog Pain Score", (scale of 0-40; 0= no pain, 40= worst pain imaginable). For this primary endpoint analysis, the total score at 6 months was evaluated.

Time frame:
6 months
Reported as:
Mean · units on a scale
Activity Based Total Visual Analog Pain Score
units on a scaleWire (Control)Plates
Activity Based Total Visual Analog Pain Score7.28 ± 4.657.20 ± 4.04
Statistical analysis
  • Wire (Control) vs Plates · t-test, 1 sided · p = 0.93 · Mean difference (final values): 0

Adverse events

Collected over 0 to 6 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Wire (Control)—24/70 (34.3%)20/70 (28.6%)
Plates—32/70 (45.7%)24/70 (34.3%)
Most frequent serious events
Showing 10 of 20
Most frequent serious events
EventWire (Control)Plates
ResternotomySurgical and medical procedures7/7011/70
Cardiac arrestCardiac disorders2/703/70
Respiratory failureRespiratory, thoracic and mediastinal disorders0/703/70
Respiratory insufficiencyRespiratory, thoracic and mediastinal disorders3/702/70
Cardiac arrhythmiasCardiac disorders2/702/70
Low cardiac outputCardiac disorders2/700/70
GI BleedGastrointestinal disorders0/702/70
StrokeNervous system disorders2/701/70
Acute renal failureRenal and urinary disorders2/702/70
AnemiaBlood and lymphatic system disorders1/701/70
Most frequent other events
Most frequent other events
EventWire (Control)Plates
Cardiac arrhythmiasCardiac disorders9/7012/70
Pleural effusionRespiratory, thoracic and mediastinal disorders10/708/70
Acute renal failureRenal and urinary disorders1/704/70

Baseline characteristics

Age, Continuous
Age, Continuous(years)Wire (Control)PlatesTotal
Mean64.0 ± 8.966.3 ± 9.865.2 ± 9.4
Sex: Female, Male
Sex: Female, Male(Participants)Wire (Control)PlatesTotal
Female181937
Male5251103
08

Study locations

6 sites
  • St. Joseph's Heart and Lung Institute
    Phoenix, Arizona 85013, United States
  • University of California Davis Medical Center
    Sacramento, California 95817, United States
  • University of Chicago
    Chicago, Illinois 60637, United States
  • Baptist Memorial Hospital
    Memphis, Tennessee 38120, United States
  • Scott & White Memorial Hospital
    Temple, Texas 76508, United States
  • Leipzig Heart Center
    Leipzig, Germany
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2008, a primary completion of Jan 2011 and a completion of Dec 2011. It does not say whether these dates are actual or estimated.

Results were first posted in Mar 2012, 1 year 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 6, 2009
First posted
Jan 8, 2009
Start
Nov 2008
Primary completionActual
Jan 2011
CompletionActual
Dec 2011
Results first posted
Mar 15, 2012
Last update
Feb 13, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00819286
Lead sponsor
Zimmer Biomet
Responsible party
Sponsor
First posted
Jan 8, 2009
Start date
Nov 2008
Primary completion
Jan 2011
Completion
Dec 2011
Results posted
Mar 15, 2012
Last update
Feb 13, 2018

Study contacts

Jai Raman, MD
study chair · University of Chicago
Michael Wong, MD
principal investigator · University of California Davis Medical Center, Sacramento, CA
Brian DeGuzmann, MD
principal investigator · St. Joseph's Medical Center, Phoenix, AZ
Sven Lehmann, MD
principal investigator · Leipzig Heart Center, Leipzig, Germany
Kenton Zehr, MD
principal investigator · Scott & White Memorial Hospital, Temple, TX
H Edward Garrett, Jr, MD
principal investigator · Baptist Memorial Hospital, Memphis, TN

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion